166 related articles for article (PubMed ID: 19853315)
1. A study of middle ear function in the treatment of nasopharyngeal carcinoma with IMRT technique.
Wang SZ; Li J; Miyamoto CT; Chen F; Zhou LF; Zhang HY; Yang G; Wang WF; Guo M; Ni XC; Wang L
Radiother Oncol; 2009 Dec; 93(3):530-3. PubMed ID: 19853315
[TBL] [Abstract][Full Text] [Related]
2. Analysis of anatomical factors controlling the morbidity of radiation-induced otitis media with effusion.
Wang SZ; Wang WF; Zhang HY; Guo M; Hoffman MR; Jiang JJ
Radiother Oncol; 2007 Dec; 85(3):463-8. PubMed ID: 18006095
[TBL] [Abstract][Full Text] [Related]
3. A treatment planning analysis of inverse-planned and forward-planned intensity-modulated radiation therapy in nasopharyngeal carcinoma.
Poon I; Xia P; Weinberg V; Sultanem K; Akazawa C; Akazawa P; Verhey L; Quivey JM; Lee N
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1625-33. PubMed ID: 18035216
[TBL] [Abstract][Full Text] [Related]
4. Middle ear effusions after radiotherapy: correlation with pre-radiotherapy nasopharyngeal tumor patterns.
Kew J; King AD; Leung SF; Tong MC; Ku PK; Wong KK; van Hasselt CA
Am J Otol; 2000 Nov; 21(6):782-5. PubMed ID: 11078063
[TBL] [Abstract][Full Text] [Related]
5. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
[TBL] [Abstract][Full Text] [Related]
6. Postirradiation otitis media with effusion in nasopharyngeal carcinoma patients treated by intensity-modulated radiotherapy.
Hsin CH; Chen TH; Liang KL; Tseng HC; Liu WS
Laryngoscope; 2013 Sep; 123(9):2148-53. PubMed ID: 23835775
[TBL] [Abstract][Full Text] [Related]
7. Incidence of long-term ipsilateral and contralateral ototoxicity following radiotherapy for nasopharyngeal carcinoma.
Wakisaka H; Yamada H; Motoyoshi K; Ugumori T; Takahashi H; Hyodo M
Auris Nasus Larynx; 2011 Feb; 38(1):95-100. PubMed ID: 20541337
[TBL] [Abstract][Full Text] [Related]
8. Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma: comparisons of four radiotherapy techniques.
Fang FM; Tsai WL; Chen HC; Hsu HC; Hsiung CY; Chien CY; Ko SF
Cancer; 2007 Jan; 109(2):313-21. PubMed ID: 17154159
[TBL] [Abstract][Full Text] [Related]
9. [Radiation-induced temporomandibular joint damage in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy].
Liu Y; Chen M; Zhao C; Lu LX; Han F; Bao Y; Huang SM; Deng XW; Lu TX; Cui NJ
Ai Zheng; 2007 Jan; 26(1):64-7. PubMed ID: 17222370
[TBL] [Abstract][Full Text] [Related]
10. Intensity-modulated vs. conformal radiotherapy of parotid gland tumors: potential impact on hearing loss.
Lamers-Kuijper E; Schwarz M; Rasch C; Mijnheer B
Med Dosim; 2007; 32(4):237-45. PubMed ID: 17980823
[TBL] [Abstract][Full Text] [Related]
11. Nasopharyngeal carcinoma in children: comparison of conventional and intensity-modulated radiotherapy.
Laskar S; Bahl G; Muckaden M; Pai SK; Gupta T; Banavali S; Arora B; Sharma D; Kurkure PA; Ramadwar M; Viswanathan S; Rangarajan V; Qureshi S; Deshpande DD; Shrivastava SK; Dinshaw KA
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):728-36. PubMed ID: 18374512
[TBL] [Abstract][Full Text] [Related]
12. Comparison of otologic complications between intensity-modulated and two-dimensional radiotherapies in nasopharyngeal carcinoma patients.
Hsin CH; Chen TH; Young YH; Liu WS
Otolaryngol Head Neck Surg; 2010 Nov; 143(5):662-8. PubMed ID: 20974336
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients.
Pan CC; Eisbruch A; Lee JS; Snorrason RM; Ten Haken RK; Kileny PR
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1393-402. PubMed ID: 15817342
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
15. Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy-a longitudinal study.
Fang FM; Chien CY; Tsai WL; Chen HC; Hsu HC; Lui CC; Huang TL; Huang HY
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):356-64. PubMed ID: 18355980
[TBL] [Abstract][Full Text] [Related]
16. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial.
Pow EH; Kwong DL; McMillan AS; Wong MC; Sham JS; Leung LH; Leung WK
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):981-91. PubMed ID: 17145528
[TBL] [Abstract][Full Text] [Related]
17. Preliminary results of a phase I/II study of simultaneous modulated accelerated radiotherapy for nondisseminated nasopharyngeal carcinoma.
Lee SW; Back GM; Yi BY; Choi EK; Ahn SD; Shin SS; Kim JH; Kim SY; Lee BJ; Nam SY; Choi SH; Kim SB; Park JH; Lee KK; Park SH; Kim JH
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):152-60. PubMed ID: 16472934
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for hearing loss in patients treated with intensity-modulated radiotherapy for head-and-neck tumors.
Zuur CL; Simis YJ; Lamers EA; Hart AA; Dreschler WA; Balm AJ; Rasch CR
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):490-6. PubMed ID: 19135315
[TBL] [Abstract][Full Text] [Related]
19. Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma.
Kim K; Wu HG; Kim HJ; Sung MW; Kim KH; Lee SH; Heo DS; Kim HJ; Park CI
Head Neck; 2009 Sep; 31(9):1121-8. PubMed ID: 19340863
[TBL] [Abstract][Full Text] [Related]
20. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
Yom SS; Liao Z; Liu HH; Tucker SL; Hu CS; Wei X; Wang X; Wang S; Mohan R; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):94-102. PubMed ID: 17321067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
